Clinical Trial Update: First-in-human Study of 7MW4911 in GI Cancer [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human Phase 1/2 trial of 7MW4911 in patients with gastrointestinal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• 7MW4911

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: GI Cancers | Phase 1, Phase 2 | Status: RECRUITING